This article was originally published in The Gray Sheet
Impedance cardiography (ICG) technology is associated with improved blood flow in 88% of heart failure patients when used to optimize programming of temporary, dual-chamber pacemakers, according to a study presented at the North American Society of Pacing and Electrophysiology meeting May 9 in San Diego. BioZ results also are closely correlated to more invasive, "gold standard" measures of cardiac output, "suggesting the former modality may have clinical utility in patients with heart failure," according to a separate study by Mark Drazner, MD, and Clyde Yancy, MD, University of Texas Southwestern Medical Center. Medtronic will co-develop bi-ventricular pacing applications for the device, according to an agreement announced in March...
You may also be interested in...
Skin hygiene is one of several categories where Edgewell Personal Care has a “right to win" after 18 months of renovations, according to the company’s 20 November Investor Day presentation. The firm has doubled its production capacity and has plans for a “full suite” of product innovation to build on Wet Ones’ 60% growth in fiscal 2020.
Considerable value has been assigned to the companies developing coronavirus vaccines. Multiple suppliers and a met clinical need may erode much of that value after the pandemic.
Guidelines outline permitted practices and patient safeguards for both physicians and technology platforms.